NCT01403545View on ClinicalTrials.gov

Evaluation of Liposomal Curcumin in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Drug Safety
Interventions
DRUG

Liposomal Curcumin

Single dose intravenous infusion of liposomal Curcumin at 10, 20, 40, 80, 120, 180 mg/m² over 120 minutes

OTHER

Placebo

5% glucose infusion over 120 minutes

Trial Locations (1)

1090

Medical University of Vienna, Department of Clinical Pharmacology, Vienna

All Listed Sponsors
lead

SignPath Pharma, Inc.

INDUSTRY

NCT01403545 - Evaluation of Liposomal Curcumin in Healthy Volunteers | Biotech Hunter | Biotech Hunter